Edmond DE Rothschild Holding S.A. Sells 130,000 Shares of Kenvue Inc. (NYSE:KVUE)

Edmond DE Rothschild Holding S.A. reduced its holdings in Kenvue Inc. (NYSE:KVUE - Free Report) by 12.7% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 890,000 shares of the company's stock after selling 130,000 shares during the quarter. Edmond DE Rothschild Holding S.A.'s holdings in Kenvue were worth $19,002,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Skba Capital Management LLC grew its position in shares of Kenvue by 6.4% in the 4th quarter. Skba Capital Management LLC now owns 601,330 shares of the company's stock valued at $12,838,000 after buying an additional 36,070 shares during the last quarter. O Shaughnessy Asset Management LLC raised its stake in Kenvue by 28.4% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 59,771 shares of the company's stock worth $1,276,000 after buying an additional 13,203 shares during the period. Schroder Investment Management Group boosted its holdings in Kenvue by 0.6% in the fourth quarter. Schroder Investment Management Group now owns 160,305 shares of the company's stock worth $3,395,000 after acquiring an additional 950 shares in the last quarter. Allstate Corp bought a new stake in shares of Kenvue during the fourth quarter valued at approximately $1,228,000. Finally, DnB Asset Management AS raised its position in shares of Kenvue by 6.3% during the fourth quarter. DnB Asset Management AS now owns 381,232 shares of the company's stock worth $8,139,000 after purchasing an additional 22,590 shares during the period. Institutional investors own 97.64% of the company's stock.

Analyst Ratings Changes

A number of analysts have commented on the stock. Deutsche Bank Aktiengesellschaft lowered shares of Kenvue from a "buy" rating to a "hold" rating and decreased their price target for the company from $25.00 to $24.00 in a research note on Thursday, December 12th. Evercore ISI began coverage on shares of Kenvue in a report on Monday, March 24th. They set an "in-line" rating and a $25.00 price objective for the company. Citigroup cut their target price on Kenvue from $25.00 to $21.00 and set a "neutral" rating for the company in a research note on Wednesday, January 15th. Barclays raised their price objective on shares of Kenvue from $21.00 to $23.00 and gave the company an "equal weight" rating in a research report on Thursday, March 27th. Finally, UBS Group lowered their target price on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $24.00.

Remove Ads

Kenvue Trading Down 3.3 %

Shares of Kenvue stock traded down $0.78 during midday trading on Friday, reaching $22.84. 5,662,096 shares of the company's stock traded hands, compared to its average volume of 16,725,067. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The stock has a 50 day moving average of $22.56 and a 200-day moving average of $22.48. The company has a market cap of $43.66 billion, a PE ratio of 43.07, a price-to-earnings-growth ratio of 2.62 and a beta of 1.25.

Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting analysts' consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. As a group, equities analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th were given a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a yield of 3.59%. The ex-dividend date was Wednesday, February 12th. Kenvue's dividend payout ratio (DPR) is 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.